GSDME epigenetic inactivation is induced by promoter DNA hypermethylation commonly59, thus, decitabine, a common anti-cancer medicine, elevates tumor cell chemosensitivity through reversing GSDME silencing 56, 57. This evidence concerns the gene GSDME and cancer.